{"id":"https://openalex.org/W2093645860","doi":"https://doi.org/10.1007/s12325-014-0153-5","title":"Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study","display_name":"Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study","publication_year":2014,"publication_date":"2014-09-01","ids":{"openalex":"https://openalex.org/W2093645860","doi":"https://doi.org/10.1007/s12325-014-0153-5","mag":"2093645860","pmid":"https://pubmed.ncbi.nlm.nih.gov/25245811","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4176953"},"language":"en","primary_location":{"id":"doi:10.1007/s12325-014-0153-5","doi":"https://doi.org/10.1007/s12325-014-0153-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-014-0153-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-014-0153-5.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s12325-014-0153-5.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074407091","display_name":"A.S. Chitnis","orcid":"https://orcid.org/0000-0002-4334-4001","observed_orcids":["https://orcid.org/0000-0002-4334-4001"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Abhishek S. Chitnis","raw_affiliation_strings":["Evidera, Suite 300, 430 Bedford Street, Lexington, MA, 02420, USA, abhishek.chitnis@evidera.com","Evidera, Lexington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera, Suite 300, 430 Bedford Street, Lexington, MA, 02420, USA, abhishek.chitnis@evidera.com","institution_ids":[]},{"raw_affiliation_string":"Evidera, Lexington, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047100651","display_name":"Michael Lee Ganz","orcid":"https://orcid.org/0000-0002-9702-2999","observed_orcids":["https://orcid.org/0000-0002-9702-2999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael L. Ganz","raw_affiliation_strings":["Evidera, Suite 300, 430 Bedford Street, Lexington, MA, 02420, USA","Evidera, Lexington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera, Suite 300, 430 Bedford Street, Lexington, MA, 02420, USA","institution_ids":[]},{"raw_affiliation_string":"Evidera, Lexington, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041628864","display_name":"Nicole N. Benjamin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicole Benjamin","raw_affiliation_strings":["Evidera, Suite 300, 430 Bedford Street, Lexington, MA, 02420, USA","Evidera, Lexington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera, Suite 300, 430 Bedford Street, Lexington, MA, 02420, USA","institution_ids":[]},{"raw_affiliation_string":"Evidera, Lexington, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020446741","display_name":"J Langer","orcid":"https://orcid.org/0000-0002-0095-1936","observed_orcids":["https://orcid.org/0000-0002-0095-1936"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jakob Langer","raw_affiliation_strings":["Novo Nordisk Inc., Plainsboro, NJ, USA","Novo Nordisk Inc., Plainsboro, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Inc., Plainsboro, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"Novo Nordisk Inc., Plainsboro, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109998971","display_name":"Mette Hammer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mette Hammer","raw_affiliation_strings":["Novo Nordisk Inc., Plainsboro, NJ, USA","Novo Nordisk Inc., Plainsboro, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Inc., Plainsboro, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"Novo Nordisk Inc., Plainsboro, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5074407091"],"corresponding_institution_ids":[],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":{"value":4790,"currency":"USD","value_usd":4790},"fwci":4.5546,"has_fulltext":true,"cited_by_count":37,"citation_normalized_percentile":{"value":0.95141548,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"31","issue":"9","first_page":"986","last_page":"999"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9940000176429749},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8999999761581421},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.5770000219345093},{"id":"https://openalex.org/keywords/severe-hypoglycemia","display_name":"severe hypoglycemia","score":0.9110000133514404},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.906000018119812},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7889999747276306},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.6769999861717224},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.8330000042915344},{"id":"https://openalex.org/keywords/american-patients","display_name":"United States patients","score":0.5659999847412109},{"id":"https://openalex.org/keywords/electronic-health-records","display_name":"electronic health records","score":0.5690000057220459},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1-analog","display_name":"glucagon-like peptide-1 analogues","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9520591497421265},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.8631071448326111},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.7404462695121765},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.7133329510688782},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6029089689254761},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6017565131187439},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5433294773101807},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5127459764480591},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.48371413350105286},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.45944488048553467},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2695651650428772}],"mesh":[{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015992","descriptor_name":"Body Mass Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s12325-014-0153-5","doi":"https://doi.org/10.1007/s12325-014-0153-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-014-0153-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-014-0153-5.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4176953","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4176953","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Adv Ther","raw_type":"Text"},{"id":"pmid:25245811","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25245811","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s12325-014-0153-5","doi":"https://doi.org/10.1007/s12325-014-0153-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-014-0153-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-014-0153-5.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2093645860.pdf","grobid_xml":"https://content.openalex.org/works/W2093645860.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1529223681","https://openalex.org/W2000074837","https://openalex.org/W2010027067","https://openalex.org/W2029876333","https://openalex.org/W2033185429","https://openalex.org/W2033768383","https://openalex.org/W2048981123","https://openalex.org/W2052980402","https://openalex.org/W2054285552","https://openalex.org/W2059158127","https://openalex.org/W2071835038","https://openalex.org/W2083415436","https://openalex.org/W2097419618","https://openalex.org/W2098459806","https://openalex.org/W2113367996","https://openalex.org/W2130933438","https://openalex.org/W2133617810","https://openalex.org/W2137352234","https://openalex.org/W2138290933","https://openalex.org/W2150423648","https://openalex.org/W2160001758","https://openalex.org/W2160274347","https://openalex.org/W2170606300","https://openalex.org/W4242364069"],"related_works":["https://openalex.org/W7095405220","https://openalex.org/W2315243425","https://openalex.org/W2222319755","https://openalex.org/W2263744287","https://openalex.org/W2122603924","https://openalex.org/W2364134519","https://openalex.org/W2315914429","https://openalex.org/W2033185429","https://openalex.org/W2778484847","https://openalex.org/W2411497318"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Clinical":[1],"trials":[2],"have":[3,25],"shown":[4],"that":[5],"liraglutide":[6,30,99,123,248],"effectively":[7],"lowers":[8],"glycated":[9],"hemoglobin":[10],"A1c":[11],"(A1C)":[12],"levels":[13,158],"in":[14,36,41,59,135,241,261,264],"adult":[15],"patients":[16,61,83,196],"with":[17,84,235],"type":[18],"2":[19],"diabetes":[20],"(T2D).":[21],"However,":[22],"no":[23],"studies":[24],"evaluated":[26],"the":[27,37,74,225,265],"effectiveness":[28,49],"of":[29,145,195,227,250],"by":[31,63,133,162,217],"body":[32,54,137,214,244],"mass":[33],"index":[34],"(BMI)":[35],"United":[38],"States":[39],"(US)":[40],"clinical":[42,48,262],"practice.":[43],"This":[44,67],"study":[45,72],"examined":[46],"liraglutide's":[47],"to":[50,219],"lower":[51],"A1C":[52,93,139,157,198,242,255],"and":[53,88,92,104,108,143,166,183,207,224,243],"weight":[55,215,245],"after":[56,246],"6":[57,155,201],"months":[58,120,202],"T2D":[60,85,236],"stratified":[62,132],"baseline":[64,96,259],"BMI.":[65,252],"METHODS:":[66],"was":[68,231],"a":[69,115],"retrospective":[70],"cohort":[71],"using":[73],"General":[75],"Electric":[76],"Centricity":[77],"electronic":[78],"medical":[79],"records":[80],"database.":[81],"Adult":[82],"(\u226518":[86],"years":[87],"BMI\u2265":[89],"25":[90],"kg/m(2))":[91],">7%":[94],"at":[95,148,200],"who":[97,109],"started":[98],"between":[100],"January":[101,105],"1,":[102],"2010":[103],"31,":[106],"2013":[107],"did":[110],"not":[111],"use":[112],"insulin":[113],"or":[114],"glucagon-like":[116],"peptide-1":[117],"analog":[118],"12":[119],"before":[121],"initiating":[122,247],"(N":[124],"=":[125,173,177,181,187,191,210],"3,005)":[126],"were":[127,151,203],"selected.":[128],"Changes":[129],"from":[130],"baseline,":[131],"BMI,":[134],"A1C,":[136],"weight,":[138],"<7%":[140,199],"goal":[141],"attainment,":[142],"incidence":[144],"severe":[146,228],"hypoglycemia":[147,229],"6-month":[149],"follow-up":[150],"examined.":[152],"RESULTS:":[153],"After":[154],"months,":[156],"decreased":[159,216],"on":[160],"average":[161],"0.95%,":[163],"1.02%,":[164],"0.99%,":[165],"0.84%":[167],"for":[168],"BMI":[169,223,260],"categories":[170],"25.0-29.9":[171],"(n":[172,176,180,186],"333),":[174],"30.0-34.9":[175],"793),":[178],"35.0-39.9":[179],"821),":[182],"\u226540.0":[184],"kg/m(2)":[185],"1,058),":[188],"respectively":[189],"(P":[190,209],"0.30).":[192],"The":[193,212],"proportions":[194],"achieving":[197],"38.2%,":[204],"37.0%,":[205],"40.9%,":[206],"41.0%":[208],"0.54).":[211],"absolute":[213],"1.5":[218],"4.0":[220],"kg":[221],"across":[222,258],"rate":[226],"(0.2%)":[230],"low.":[232],"CONCLUSION:":[233],"Patients":[234],"experienced":[237],"statistically":[238],"significant":[239],"decreases":[240],"regardless":[249],"their":[251],"Liraglutide":[253],"reduced":[254],"equally":[256],"well":[257],"practice":[263],"US.":[266]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}